Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-133-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1 Sep 2000 - 25 Sep 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD Guideline 406 and in compliance with GLP
- Justification for type of information:
- The data for this substance has been generated in a read-across approach. Please see the read-across justification attached in section 13.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Reliable data are already available for this substance
Test material
- Reference substance name:
- Fatty acids, vegetable-oil, reaction products with tetraethylenepentamine
- EC Number:
- 273-652-9
- EC Name:
- Fatty acids, vegetable-oil, reaction products with tetraethylenepentamine
- Cas Number:
- 68991-84-4
- IUPAC Name:
- 68991-84-4
- Reference substance name:
- Fatty acids C16-18, C18 unsat reaction products with tetraethylenepentamine
- IUPAC Name:
- Fatty acids C16-18, C18 unsat reaction products with tetraethylenepentamine
- Details on test material:
- Certificate of analysis included in report.
Name: Base 136
description: Sel thioclycolate dímidazoline
CASno:: 68991-84-4
Batch: Lot AB771
mw = 581 (pure salt)
Aspect: brown solid (@25ºC)
pH: 9,25 (5% inwater)
acid number: 122 mg KOH/g
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
Hartley Cd: (HA) BR, Caesarian obtained, Barrier sustained - Virus Antibody Free (COBS - VAF®)
- Source: Charles River France, 76410 Saint-Aubin-lès-Elbeuf, France.
- Age at study initiation: 1-3 months
- Weight at study initiation: 379 ± 13 g for the males and 374 ± 13 g for the females.
- Housing: individually in polycarbonate cages with stainless steel lid (48 cm x 27 cm x 20 cm) equipped with a polypropylene bottle. Dust-free sawdust was provided as litter (SICSA, 94142 Alfortville, France). Sawdust is analysed by the supplier for composition and contaminant levels.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2°C
- Humidity (%): 30 to 70%
- Air changes (per hr): 12 cycles/hour of filtered, non-recycled air.
- Photoperiod (hrs dark / hrs light): 12 h/12 h
IN-LIFE DATES: From: 1 Sep 2000 To: 25 Sep 2000
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- The dosage form preparation which could pass through a needle and into the dermis had a maximum concentration of 10% (w/w).
Intradermal induction: 0.1%
epicutaneous induction: 5%
epicutaneous challenge: 1%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- The dosage form preparation which could pass through a needle and into the dermis had a maximum concentration of 10% (w/w).
Intradermal induction: 0.1%
epicutaneous induction: 5%
epicutaneous challenge: 1%
- No. of animals per dose:
- Control: 5 animals/sex
Treated group: 10 animals /sex - Details on study design:
- RANGE FINDING TESTS:
Series of test substance concentrations were tested by intra dermal (0.1, 1, 5, 10% with and without FCA) and epicutaneous route (0.1, 1, 5, 10, 50 100%)
Intradermal: Concentrations of 1% and higher were corrosive. 0.1% resulted to irritation visible during all reported observation day from 24h to 6 days. This concentration was selected for the main study.
Epicutaneous: 5% was the lowest concentration leading to irritation (grade 2: moderate and confluent erythema). This concentration was used for epidermal induction. 1% was without signs of irritation, and was select for challenge concentration.
MAIN STUDY
A. INDUCTION EXPOSURE
-Day 1
The scapular region was clipped and three pairs of intradermal injections (0.1 mL/site) were made in this area as follows:
A) A 1:1 w/w mixture of FCA (Sigma, France) with 0.9% NaCl.
B) The test substance at a 50% concentration in 0.9% NaCl.
C) A 1:1 w/w mixture of the undiluted test substance and FCA.
Note: One of each pair was on each side of the midline and from cranial A) to caudal C).
Controls were treated similarly, but vehicle instead of testsubstance was used.
Day 7
The scapular area between the injection sites was clipped .
Day 8
a pad of filter paper (approximately 8 cm2) was fully-loaded with the test substance at the concentration of 5% (w/w) and was then applied to the interscapular region of the animals of the treated group.
The animals of the control group received an application of the vehicle alone under the same experimental conditions.
The pad was held in place for 48 hours by means of an adhesive hypoallergenic dressing and an adhesive anallergenic waterproof plaster.
B. CHALLENGE EXPOSURE
Day 21: Clipped and shaved each flank.
Day 22: the animals of treated and control groups received an application of the test substance and vehicle. The filter paper of a chamber (Finn Chamber®) was fully-loaded with the test substance at the concentration of 1% (w/w) and was then applied to a clipped area of the skin of the posterior right flank of all animals. The vehicle was applied under the same experimental conditions to the skin of the posterior left flank.
Twenty-four and 48 hours after removal of the dressing of the challenge application, both flanks of the treated and control animals were observed in order to evaluate cutaneous reactions, according to the following scale:
• 0 - no visible change
• 1 - discrete or patchy erythema
• 2 - moderate and confluent erythema
• 3 - intense erythema
Any observed oedema and other lesions were noted..
In life examinations:
At least one a day for clinical signs and mortality
Body weights: Prior to start and at termination of the study. - Positive control substance(s):
- yes
Results and discussion
- Positive control results:
- The sensitivity of the experimental technique is regularly assessed using a known moderate sensitizer, MERCAPTOBENZOTHIAZOLE. In a recent study performed under CIT experimental conditions, the strain of guinea pigs used showed a satisfactory sensitization response in 70% animals.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1% w/w
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Two animals skin injured by dressing, making scoring difficult/impossible; one of these animals also showed crusts.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1% w/w. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Two animals skin injured by dressing, making scoring difficult/impossible; one of these animals also showed crusts..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5% w/w
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Two animals skin injured by dressing, making scoring difficult/impossible.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 5% w/w. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Two animals skin injured by dressing, making scoring difficult/impossible..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 19
- Total no. in group:
- 19
- Clinical observations:
- One animal died study day 11 (before challenge). Dryness of skin and/or crusts observed in most animals.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5%. No with. + reactions: 19.0. Total no. in groups: 19.0. Clinical observations: One animal died study day 11 (before challenge). Dryness of skin and/or crusts observed in most animals..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5% w/w
- No. with + reactions:
- 19
- Total no. in group:
- 19
- Clinical observations:
- Dryness of skin and/or crusts observed in all animals.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5% w/w. No with. + reactions: 19.0. Total no. in groups: 19.0. Clinical observations: Dryness of skin and/or crusts observed in all animals..
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Reactions were observed in all animals of treatment group and none in the control. Cutaneous effects were attributed to delayed contact hypersenisitivity.
- Executive summary:
The potential of the test substance BASE 136 (batch No. AB77l) to induce delayed contact hypersensitivity was evaluated in guinea pigs according to the maximization method of Magnusson and Kligman and to OECD (No. 406, 17th July 1992) and EC (96/S4/EEC, B.6, 30 July 1996) guidelines.
The study was conducted in compliance with the principles of Good Laboratory Practice Regulations.
Thirty guinea pigs were allocated to two groups: a control group of five males and five females and a treated group of ten males and ten females.
On day 1, three pairs of intradermal injections were performed in the interscapular region of all animals:
- Freund's complete adjuvant (FCA) diluted at 50% with 0.9% NaCl (both groups),
- test substance at the chosen concentration in the chosen vehicle (treated group) or vehicle alone (control group),
- test substance at the chosen concentration in a mixture FCA/0.9% NaCl 50/50 (treated group) or vehicle at the concentration of SO% in a mixture FCAl/0.9% NaCl 50/50 (control group).
On day 8, the test substance (treated group) or the vehicle (control group) was applied topically to the same test site, which was then covered by an occlusive dressing for 48 hours.
On day 22, all animals of the treated and control groups were challenged by a cutaneous application of the test substance to the right flank. The left flank served as control and received the vehicle only. Test substance and vehicle were maintained under an occlusive dressing for 24 hours.
Skin reactions were evaluated approximately 24 and 48 hours after removal of the dressing.
Test substance concentrations were as follows:
Induction (treated group)
- intradermal injections (day 1): BASE 136 at the concentration of 0.1% (w/w) in sterile isotonic saline solution (0.9% NaCl),
- topical application (day 8): BASE 136 at the concentration of 5% (w/w) in sterile isotonic saline solution (0.9% NaCl).
Challenge (all groups)
- topical application (day 22): BASE 136 at the concentration of 1% (w/w) in sterile isotonic saline solution (0.9% NaCl).
At the end of the study, animals were killed without examination of internal organs.
Skin samples were taken from the challenge application sites of all the animals.
No histological examination was performed.
Results
No clinical signs and no deaths related to treatment were noted during the study.
These results on Fatty acids C16-18, C18 unsat reaction products with tetraethylenepentamine are fully valid for Tall oil, reaction products with tetraethylene-pentamine (Amidoamine/Imidazoline) as both substances have the same fatty acid distribution and both used TEPA as starting material.
After the challenge application, no relevant cutaneous reactions were observed in the animals of the control group.
In the treated group, a discrete or moderate erythema was noted in all animals. An oedema was recorded in 11/19 animals. Dryness of the skin and/or crusts were observed all animals. The observed cutaneous were attributed to delayed contact hypersensitivity.
Conclusion
Under our experimental conditions and according to the maximization method of Magnusson and Kligman, the test substance BASE 136 (batch No. AB771) induces delayed contact hypersensitivity in 19/19 (100%) guinea pigs.
According to the classification criteria laid down in Directive 93/21/EEC (27th April 1993) adapting to technical progress for the eighteenth time Council Directive 67/548/EEC, the test substance should be considered as a skin sensitizer.
These results are valid also for tall oil + TEPA, as Fatty acids C16-18, C18 unsat and Tall oil are only marginally differing in chain lengths distributions, and it is considered that both their reaction products with TEPA are principally the same when evaluating for sensitisation.
These results lead to classification according to CLP (ATP 2): Skin sensitiser Cat.1A (GPMT ≥ 30% positive at ≤ 0.1% i.d. induction)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
